{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:48:55Z","timestamp":1791406135292,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms7218","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T04:26:06Z","timestamp":1422937566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation"],"prefix":"10.1038","volume":"6","author":[{"given":"Virginie","family":"Vives","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Cres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Busson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Ferrandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Gaelle","family":"Planson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahel","family":"Zeghouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Cherfils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Malaval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blangy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"BFncomms7218_CR1","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1152\/japplphysiol.00564.2003","volume":"95","author":"E Seeman","year":"2003","unstructured":"Seeman, E. Invited Review: Pathogenesis of osteoporosis. J. Appl. Physiol. 95, 2142\u20132151 (2003).","journal-title":"J. Appl. Physiol."},{"key":"BFncomms7218_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron, R., Ferrari, S. & Russell, R. G. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677\u2013692 (2011).","journal-title":"Bone"},{"key":"BFncomms7218_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black, D. M. et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. New Engl. J. Med. 349, 1207\u20131215 (2003).","journal-title":"New Engl. J. Med."},{"key":"BFncomms7218_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas, L., Solomon, D. H. & Kim, S. C. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J. Bone. Miner. Res. 28, 1729\u20131737 (2013).","journal-title":"J. Bone. Miner. Res."},{"key":"BFncomms7218_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","volume":"12","author":"J Yamashita","year":"2012","unstructured":"Yamashita, J. & McCauley, L. K. Antiresorptives and osteonecrosis of the jaw. J. Evid. Based Dent. Pract. 12, 233\u2013247 (2012).","journal-title":"J. Evid. Based Dent. Pract."},{"key":"BFncomms7218_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bone.2012.06.015","volume":"51","author":"BJ Kim","year":"2012","unstructured":"Kim, B. J. et al. Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway. Bone 51, 431\u2013440 (2012).","journal-title":"Bone"},{"key":"BFncomms7218_CR7","first-page":"666","volume":"123","author":"S Lotinun","year":"2013","unstructured":"Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 123, 666\u2013681 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFncomms7218_CR8","doi-asserted-by":"publisher","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S. & Oursler, M. J. Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 105, 20764\u201320769 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncomms7218_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00223-013-9741-7","volume":"94","author":"K Henriksen","year":"2014","unstructured":"Henriksen, K., Karsdal, M. A. & Martin, T. J. Osteoclast-derived coupling factors in bone remodeling. Calcif. Tissue Int. 94, 88\u201397 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"BFncomms7218_CR10","doi-asserted-by":"publisher","first-page":"e28119","DOI":"10.4161\/sgtp.28119","volume":"5","author":"H Touaitahuata","year":"2014","unstructured":"Touaitahuata, H., Blangy, A. & Vives, V. Modulation of osteoclast differentiation and bone resorption by Rho GTPases. Small GTPases 5, e28119 (2014).","journal-title":"Small GTPases"},{"key":"BFncomms7218_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/jbmr.282","volume":"26","author":"V Vives","year":"2011","unstructured":"Vives, V. et al. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J. Bone. Miner. Res. 26, 1099\u20131110 (2011).","journal-title":"J. Bone. Miner. Res."},{"key":"BFncomms7218_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ydbio.2014.06.020","volume":"393","author":"H Touaitahuata","year":"2014","unstructured":"Touaitahuata, H., Cres, G., de Rossi, S., Vives, V. & Blangy, A. The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth. Dev. Biol. 393, 57\u201370 (2014).","journal-title":"Dev. Biol."},{"key":"BFncomms7218_CR13","doi-asserted-by":"publisher","first-page":"25341","DOI":"10.1074\/jbc.M111.236455","volume":"286","author":"K Kulkarni","year":"2011","unstructured":"Kulkarni, K., Yang, J., Zhang, Z. & Barford, D. Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors. J. Biol. Chem. 286, 25341\u201325351 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFncomms7218_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jcp.22159","volume":"224","author":"B Frenkel","year":"2010","unstructured":"Frenkel, B. et al. Regulation of adult bone turnover by sex steroids. J. Cell. Physiol. 224, 305\u2013310 (2010).","journal-title":"J. Cell. Physiol."},{"key":"BFncomms7218_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich, K. & Smolen, J. S. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug. Discov. 11, 234\u2013250 (2012).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"BFncomms7218_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A. & McCauley, L. K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer. 11, 411\u2013425 (2011).","journal-title":"Nat. Rev. Cancer."},{"key":"BFncomms7218_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00223-008-9150-5","volume":"83","author":"J Klinck","year":"2008","unstructured":"Klinck, J. & Boyd, S. K. The magnitude and rate of bone loss in ovariectomized mice differs among inbred strains as determined by longitudinal in vivo micro-computed tomography. Calcif. Tissue Int. 83, 70\u201379 (2008).","journal-title":"Calcif. Tissue Int."},{"key":"BFncomms7218_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand, D. D., Latham, K. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 2, 1269\u20131275 (2007).","journal-title":"Nat. Protoc."},{"key":"BFncomms7218_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fimmu.2014.00116","volume":"5","author":"KH Toomer","year":"2014","unstructured":"Toomer, K. H. & Chen, Z. Autoimmunity as a double agent in tumor killing and cancer promotion. Front. Immunol. 5, 116 (2014).","journal-title":"Front. Immunol."},{"key":"BFncomms7218_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","volume":"8","author":"H Takayanagi","year":"2012","unstructured":"Takayanagi, H. New developments in osteoimmunology. Nat. Rev. Rheumatol. 8, 684\u2013689 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFncomms7218_CR21","first-page":"6876","volume":"48","author":"F Arguello","year":"1988","unstructured":"Arguello, F., Baggs, R. B. & Frantz, C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 48, 6876\u20136881 (1988).","journal-title":"Cancer Res."},{"key":"BFncomms7218_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0024-3205(01)01454-0","volume":"70","author":"K Nakamura","year":"2002","unstructured":"Nakamura, K. et al. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model. Life Sci. 70, 791\u2013798 (2002).","journal-title":"Life Sci."},{"key":"BFncomms7218_CR23","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane, E. et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J. Bone. Miner. Res. 25, 2267\u20132294 (2010).","journal-title":"J. Bone. Miner. Res."},{"key":"BFncomms7218_CR24","doi-asserted-by":"publisher","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","volume":"285","author":"DD Pierroz","year":"2010","unstructured":"Pierroz, D. D. et al. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL. J. Biol. Chem. 285, 28164\u201328173 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFncomms7218_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.biocel.2008.12.007","volume":"41","author":"H Brazier","year":"2009","unstructured":"Brazier, H., Pawlak, G., Vives, V. & Blangy, A. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int. J. Biochem. Cell Biol. 41, 1391\u20131401 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFncomms7218_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.chembiol.2009.04.012","volume":"16","author":"N Bouquier","year":"2009","unstructured":"Bouquier, N. et al. A cell active chemical GEF inhibitor selectively targets the Trio\/RhoG\/Rac1 signaling pathway. Chem. Biol. 16, 657\u2013666 (2009).","journal-title":"Chem. Biol."},{"key":"BFncomms7218_CR27","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/emboj\/17.13.3651","volume":"17","author":"S Beraud-Dufour","year":"1998","unstructured":"Beraud-Dufour, S. et al. A glutamic finger in the guanine nucleotide exchange factor ARNO displaces Mg2+ and the beta-phosphate to destabilize GDP on ARF1. EMBO J. 17, 3651\u20133659 (1998).","journal-title":"EMBO J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms7218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7218","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:14:27Z","timestamp":1672902867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms7218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,5]]}},"alternative-id":["BFncomms7218"],"URL":"https:\/\/doi.org\/10.1038\/ncomms7218","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]},"assertion":[{"value":"24 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Anne Blangy is inventor of patents owned by the CNRS and Montpellier University related to the development of Dock5 inhibitors (WO\/2010\/020647 and US Patent Application no: 2013\/0165,523). All other authors state that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6218"}}